Pancreatic beta cell lines and their applications in diabetes mellitus research

Masa Skelin1, Marjan Rupnik, Avrelija Cencic

  • 1University of Maribor, Slovenia.

ALTEX
|August 6, 2010
PubMed

Insights

Developing functional insulin-secreting beta cell lines is challenging. Current cell lines, while useful, have limitations in glucose regulation, highlighting the need for improved human or pig beta cell models for diabetes research.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Diabetes Mellitus Research

Background:

  • Significant efforts over 30 years to create insulin-secreting beta cell lines with normal regulation have yielded limited success.
  • Existing immortalized beta cell lines (e.g., RIN, HIT, MIN, INS-1, TC) face challenges with glucose responsiveness and sensitivity.
  • The 3Rs principles (Replacement, Reduction, Refinement) and limited primary beta cell availability drive the search for alternative models.

Purpose of the Study:

  • To review the development and limitations of existing immortalized insulin-secreting cell lines.
  • To highlight the ongoing need for a "normal" beta cell line of human or pig origin.
  • To discuss methods used in creating beta cell lines, including X-rays, viruses, and transgenic approaches.

Main Methods:

  • Review of literature on immortalized beta cell line development.
  • Analysis of characteristics of commonly used cell lines (RIN, HIT, MIN, INS-1, TC).
  • Examination of induction methods: X-rays, viruses, in vitro transformation, transgenic mice, and non-islet cells.

Main Results:

  • Established cell lines produce insulin, glucagon, and somatostatin but exhibit variable and often abnormal glucose regulation.
  • Some cell lines show poor glucose responsiveness, while others are overly sensitive.
  • Despite limitations, these cell lines have contributed valuable insights into beta cell physiology.

Conclusions:

  • Current immortalized beta cell lines have significant drawbacks in mimicking physiological glucose-regulated insulin secretion.
  • There is an unmet need for developing "normal" beta cell lines from human or pig sources.
  • Advancements in beta cell line development are crucial for future diabetes mellitus research.